Format

Send to

Choose Destination
Intern Med J. 2014 Sep;44(9):841-5. doi: 10.1111/imj.12530.

Dilemmas in the compassionate supply of investigational cancer drugs.

Author information

1
Centre for Values, Ethics and Law in Medicine, School of Public Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.

Abstract

In Australia, patients who want to access medicines that are not yet approved have only two options: to enroll in a clinical trial if they are eligible, or obtain their medicine through 'compassionate supply', which is provided at the discretion of the manufacturer. In this article, we explore ethical issues associated with the provision of oncology medicines that are still in development, either prior to regulatory approval or government reimbursement.

KEYWORDS:

ethics; evidence-based medicine; health services accessibility; oncology

PMID:
25201421
DOI:
10.1111/imj.12530
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center